{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:58:57Z","timestamp":1783781937674,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":803,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","award":["M2015214"],"award-info":[{"award-number":["M2015214"]}],"id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30EY003790"],"award-info":[{"award-number":["P30EY003790"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajp.amjpathol.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ajpath.2017.06.015","type":"journal-article","created":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T18:30:46Z","timestamp":1500661846000},"page":"2208-2221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["A Proinflammatory Function of Toll-Like Receptor 2 in the Retinal Pigment Epithelium as a Novel Target for Reducing Choroidal Neovascularization in Age-Related Macular Degeneration"],"prefix":"10.1016","volume":"187","author":[{"given":"Lili","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihua","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei Ying V.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Mackey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2575-3837","authenticated-orcid":false,"given":"Mariasilvia","family":"Evangelista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiju","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Adamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kameran","family":"Lashkari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Foxton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Shima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4982-1999","authenticated-orcid":false,"given":"Yin Shan","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2017.06.015_bib1","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1056\/NEJMoa042760","article-title":"Pegaptanib for neovascular age-related macular degeneration","volume":"351","author":"Gragoudas","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2017.06.015_bib2","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2017.06.015_bib3","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2017.06.015_bib4","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0002-9440(10)64891-2","article-title":"Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment","volume":"160","author":"Ohno-Matsui","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2017.06.015_bib5","first-page":"281","article-title":"Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization","volume":"151","author":"Okamoto","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2017.06.015_bib6","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/jcp.20110","article-title":"Increased expression of VEGF in retinal pigmented epithelial cells is not sufficient to cause choroidal neovascularization","volume":"201","author":"Oshima","year":"2004","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ajpath.2017.06.015_bib7","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0002-9440(10)64063-1","article-title":"Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium","volume":"158","author":"Schwesinger","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2017.06.015_bib8","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.ophtha.2016.03.045","article-title":"Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: the Comparison of Age-Related Macular Degeneration Treatments Trials","volume":"123","author":"Maguire","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajpath.2017.06.015_bib9","doi-asserted-by":"crossref","first-page":"786870","DOI":"10.1155\/2012\/786870","article-title":"Anti-VEGF treatment strategies for wet AMD","volume":"2012","author":"Kovach","year":"2012","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.ajpath.2017.06.015_bib10","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1016\/j.ophtha.2013.03.046","article-title":"Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP)","volume":"120","author":"Rofagha","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajpath.2017.06.015_bib11","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/ICU.0b013e32835fefee","article-title":"Long-term follow-up of vascular endothelial growth factor inhibitor therapy for neovascular age-related macular degeneration","volume":"24","author":"Scott","year":"2013","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ajpath.2017.06.015_bib12","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1136\/bjo.2007.118562","article-title":"Pegaptanib and ranibizumab for neovascular age-related macular degeneration: a systematic review","volume":"91","author":"Takeda","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajpath.2017.06.015_bib13","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.ajpath.2012.12.032","article-title":"VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucoma","volume":"182","author":"Foxton","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2017.06.015_bib14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2353\/ajpath.2007.061237","article-title":"Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury","volume":"171","author":"Nishijima","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2017.06.015_bib15","doi-asserted-by":"crossref","first-page":"e3554","DOI":"10.1371\/journal.pone.0003554","article-title":"Endogenous VEGF is required for visual function: evidence for a survival role on muller cells and photoreceptors","volume":"3","author":"Saint-Geniez","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2017.06.015_bib16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/eye.2010.196","article-title":"The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment","volume":"25","author":"Wang","year":"2011","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ajpath.2017.06.015_bib17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jaut.2009.09.003","article-title":"Autoimmunity in retinal degeneration: autoimmune retinopathy and age-related macular degeneration","volume":"33","author":"Morohoshi","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.ajpath.2017.06.015_bib18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1126\/science.1110189","article-title":"Complement factor H polymorphism and age-related macular degeneration","volume":"308","author":"Edwards","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2017.06.015_bib19","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1073\/pnas.0501536102","article-title":"A common haplotype in the complement regulatory gene factor H (HF1\/CFH) predisposes individuals to age-related macular degeneration","volume":"102","author":"Hageman","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2017.06.015_bib20","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1126\/science.1110359","article-title":"Complement factor H variant increases the risk of age-related macular degeneration","volume":"308","author":"Haines","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2017.06.015_bib21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1109557","article-title":"Complement factor H polymorphism in age-related macular degeneration","volume":"308","author":"Klein","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2017.06.015_bib22","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1167\/iovs.03-0038","article-title":"Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization","volume":"44","author":"Espinosa-Heidmann","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2017.06.015_bib23","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0002-9394(14)77270-8","article-title":"Pathologic features of surgically excised subretinal neovascular membranes in age-related macular degeneration","volume":"112","author":"Lopez","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajpath.2017.06.015_bib24","first-page":"1891","article-title":"The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes","volume":"40","author":"Oh","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2017.06.015_bib25","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1167\/iovs.03-0097","article-title":"Macrophage depletion inhibits experimental choroidal neovascularization","volume":"44","author":"Sakurai","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2017.06.015_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00109-008-0418-z","article-title":"Age-related macular degeneration: activation of innate immunity system via pattern recognition receptors","volume":"87","author":"Kaarniranta","year":"2009","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.ajpath.2017.06.015_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jneuroim.2004.04.018","article-title":"Innate immunity in the retina: Toll-like receptor (TLR) signaling in human retinal pigment epithelial cells","volume":"153","author":"Kumar","year":"2004","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.ajpath.2017.06.015_bib28","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nri3459","article-title":"Immunology of age-related macular degeneration","volume":"13","author":"Ambati","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ajpath.2017.06.015_bib29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.biochem.76.060305.151318","article-title":"Structure and function of Toll receptors and their ligands","volume":"76","author":"Gay","year":"2007","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.ajpath.2017.06.015_bib30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fimmu.2012.00079","article-title":"The role of TLR2 in infection and immunity","volume":"3","author":"Oliveira-Nascimento","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajpath.2017.06.015_bib31","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/nature09421","article-title":"Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands","volume":"467","author":"West","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2017.06.015_bib32","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1100\/tsw.2011.92","article-title":"Toll-like receptors in angiogenesis","volume":"11","author":"Grote","year":"2011","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.ajpath.2017.06.015_bib33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0039-6257(00)00140-5","article-title":"The role of oxidative stress in the pathogenesis of age-related macular degeneration","volume":"45","author":"Beatty","year":"2000","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ajpath.2017.06.015_bib34","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1189\/jlb.1209775","article-title":"Endogenous ligands of TLR2 and TLR4: agonists or assistants?","volume":"87","author":"Erridge","year":"2010","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.ajpath.2017.06.015_bib35","doi-asserted-by":"crossref","first-page":"e106421","DOI":"10.1371\/journal.pone.0106421","article-title":"The oxidative stress product carboxyethylpyrrole potentiates TLR2\/TLR1 inflammatory signaling in macrophages","volume":"9","author":"Saeed","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2017.06.015_bib36","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1167\/iovs.09-4464","article-title":"Choroidal neovascularization enhanced by Chlamydia pneumoniae via Toll-like receptor 2 in the retinal pigment epithelium","volume":"51","author":"Fujimoto","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2017.06.015_bib37","first-page":"1826","article-title":"Increase in peripheral blood mononuclear cell Toll-like receptor 2\/3 expression and reactivity to their ligands in a cohort of patients with wet age-related macular degeneration","volume":"19","author":"Zhu","year":"2013","journal-title":"Mol Vis"},{"key":"10.1016\/j.ajpath.2017.06.015_bib38","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1007\/s00417-005-1169-y","article-title":"Identification of Chlamydia pneumoniae within human choroidal neovascular membranes secondary to age-related macular degeneration","volume":"243","author":"Kalayoglu","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajpath.2017.06.015_bib39","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1016\/j.ajpath.2015.04.029","article-title":"Novel CCR3 antagonists are effective mono- and combination inhibitors of choroidal neovascular growth and vascular permeability","volume":"185","author":"Nagai","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2017.06.015_bib40","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1167\/iovs.14-13989","article-title":"Spontaneous CNV in a novel mutant mouse is associated with early VEGF-A-driven angiogenesis and late-stage focal edema, neural cell loss, and dysfunction","volume":"55","author":"Nagai","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2017.06.015_bib41","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1167\/iovs.15-17264","article-title":"IL-18 immunotherapy for neovascular AMD: tolerability and efficacy in nonhuman primates","volume":"56","author":"Doyle","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2017.06.015_bib42","first-page":"2032","article-title":"Experimental models for study of retinal pigment epithelial physiology and pathophysiology","volume":"45","author":"Maminishkis","year":"2010","journal-title":"J Vis Exp"},{"key":"10.1016\/j.ajpath.2017.06.015_bib43","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1167\/iovs.15-17758","article-title":"PGC-1alpha induces human RPE oxidative metabolism and antioxidant capacity","volume":"57","author":"Iacovelli","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2017.06.015_bib44","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4049\/jimmunol.168.2.554","article-title":"Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines","volume":"168","author":"Zarember","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2017.06.015_bib45","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/eji.200424955","article-title":"Toll-like receptor 6-independent signaling by diacylated lipopeptides","volume":"35","author":"Buwitt-Beckmann","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ajpath.2017.06.015_bib46","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12026-009-8146-1","article-title":"Immune regulation in the retina","volume":"47","author":"Detrick","year":"2010","journal-title":"Immunol Res"},{"key":"10.1016\/j.ajpath.2017.06.015_bib47","doi-asserted-by":"crossref","first-page":"14682","DOI":"10.1073\/pnas.222551899","article-title":"Drusen proteome analysis: an approach to the etiology of age-related macular degeneration","volume":"99","author":"Crabb","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2017.06.015_bib48","doi-asserted-by":"crossref","first-page":"42027","DOI":"10.1074\/jbc.M305460200","article-title":"Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration","volume":"278","author":"Gu","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2017.06.015_bib49","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1167\/iovs.12-10655","article-title":"NLRP3 inflammasome activation in retinal pigment epithelial cells by lysosomal destabilization: implications for age-related macular degeneration","volume":"54","author":"Tseng","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2017.06.015_bib50","doi-asserted-by":"crossref","first-page":"e1002671","DOI":"10.1371\/journal.ppat.1002671","article-title":"Macrophage activation associated with chronic murine cytomegalovirus infection results in more severe experimental choroidal neovascularization","volume":"8","author":"Cousins","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ajpath.2017.06.015_bib51","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ajo.2004.03.018","article-title":"The association of prior cytomegalovirus infection with neovascular age-related macular degeneration","volume":"138","author":"Miller","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajpath.2017.06.015_bib52","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4049\/jimmunol.168.1.348","article-title":"Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi","volume":"168","author":"Wooten","year":"2002","journal-title":"J Immunol"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944017302043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944017302043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T23:53:33Z","timestamp":1617234813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944017302043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0002944017302043"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2017.06.015","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Proinflammatory Function of Toll-Like Receptor 2 in the Retinal Pigment Epithelium as a Novel Target for Reducing Choroidal Neovascularization in Age-Related Macular Degeneration","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2017.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}